ID   CTCF_HUMAN              Reviewed;         727 AA.
AC   P49711; B5MC38; Q53XI7; Q59EL8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   28-JUN-2023, entry version 217.
DE   RecName: Full=Transcriptional repressor CTCF;
DE   AltName: Full=11-zinc finger protein;
DE   AltName: Full=CCCTC-binding factor;
DE   AltName: Full=CTCFL paralog;
GN   Name=CTCF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=8649389; DOI=10.1128/mcb.16.6.2802;
RA   Filippova G.N., Fagerlie S., Klenova E.M., Myers C., Dehner Y., Goodwin G.,
RA   Neiman P.E., Collins S.J., Lobanenkov V.V.;
RT   "An exceptionally conserved transcriptional repressor, CTCF, employs
RT   different combinations of zinc fingers to bind diverged promoter sequences
RT   of avian and mammalian c-myc oncogenes.";
RL   Mol. Cell. Biol. 16:2802-2813(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=9591631;
RX   DOI=10.1002/(sici)1098-2264(199805)22:1<26::aid-gcc4>3.3.co;2-w;
RA   Filippova G.N., Lindblom A., Meincke L.J., Klenova E.M., Neiman P.E.,
RA   Collins S.J., Doggett N.A., Lobanenkov V.V.;
RT   "A widely expressed transcription factor with multiple DNA sequence
RT   specificity, CTCF, is localized at chromosome segment 16q22.1 within one of
RT   the smallest regions of overlap for common deletions in breast and prostate
RT   cancers.";
RL   Genes Chromosomes Cancer 22:26-36(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS WILMS TUMOR TRP-339 AND
RP   GLN-448, VARIANT BREAST TUMOR GLU-344, AND VARIANT PROSTATE TUMOR ARG-345.
RX   PubMed=11782357;
RA   Filippova G.N., Qi C.-F., Ulmer J.E., Moore J.M., Ward M.D., Hu Y.J.,
RA   Loukinov D.I., Pugacheva E.M., Klenova E.M., Grundy P.E., Feinberg A.P.,
RA   Cleton-Jansen A.-M., Moerland E.W., Cornelisse C.J., Suzuki H., Komiya A.,
RA   Lindblom A., Dorion-Bonnet F., Neiman P.E., Morse H.C. III, Collins S.J.,
RA   Lobanenkov V.V.;
RT   "Tumor-associated zinc finger mutations in the CTCF transcription factor
RT   selectively alter its DNA-binding specificity.";
RL   Cancer Res. 62:48-52(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 471-479 AND 483-487, AND TRANSCRIPTIONAL ACTIVATION OF
RP   APP.
RX   PubMed=9407128; DOI=10.1074/jbc.272.52.33353;
RA   Vostrov A.A., Quitschke W.W.;
RT   "The zinc finger protein CTCF binds to the APBbeta domain of the amyloid
RT   beta-protein precursor promoter. Evidence for a role in transcriptional
RT   activation.";
RL   J. Biol. Chem. 272:33353-33359(1997).
RN   [10]
RP   REVIEW.
RX   PubMed=12191639; DOI=10.1016/s1044-579x(02)00060-3;
RA   Klenova E.M., Morse H.C. III, Ohlsson R., Lobanenkov V.V.;
RT   "The novel BORIS + CTCF gene family is uniquely involved in the epigenetics
RT   of normal biology and cancer.";
RL   Semin. Cancer Biol. 12:399-414(2002).
RN   [11]
RP   FUNCTION.
RX   PubMed=11743158; DOI=10.1126/science.1065982;
RA   Chao W., Huynh K.D., Spencer R.J., Davidow L.S., Lee J.T.;
RT   "CTCF, a candidate trans-acting factor for X-inactivation choice.";
RL   Science 295:345-347(2002).
RN   [12]
RP   SUBCELLULAR LOCATION, AND ASSOCIATION WITH H19 ICR.
RX   PubMed=16107875; DOI=10.1038/sj.emboj.7600793;
RA   Burke L.J., Zhang R., Bartkuhn M., Tiwari V.K., Tavoosidana G.,
RA   Kurukuti S., Weth C., Leers J., Galjart N., Ohlsson R., Renkawitz R.;
RT   "CTCF binding and higher order chromatin structure of the H19 locus are
RT   maintained in mitotic chromatin.";
RL   EMBO J. 24:3291-3300(2005).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16595548; DOI=10.1242/jcs.02890;
RA   Torrano V., Navascues J., Docquier F., Zhang R., Burke L.J., Chernukhin I.,
RA   Farrar D., Leon J., Berciano M.T., Renkawitz R., Klenova E., Lafarga M.,
RA   Delgado M.D.;
RT   "Targeting of CTCF to the nucleolus inhibits nucleolar transcription
RT   through a poly(ADP-ribosyl)ation-dependent mechanism.";
RL   J. Cell Sci. 119:1746-1759(2006).
RN   [14]
RP   INTERACTION WITH CHD8.
RX   PubMed=16949368; DOI=10.1016/j.molcel.2006.08.008;
RA   Ishihara K., Oshimura M., Nakao M.;
RT   "CTCF-dependent chromatin insulator is linked to epigenetic remodeling.";
RL   Mol. Cell 23:733-742(2006).
RN   [15]
RP   FUNCTION.
RX   PubMed=16815976; DOI=10.1073/pnas.0600326103;
RA   Kurukuti S., Tiwari V.K., Tavoosidana G., Pugacheva E., Murrell A.,
RA   Zhao Z., Lobanenkov V., Reik W., Ohlsson R.;
RT   "CTCF binding at the H19 imprinting control region mediates maternally
RT   inherited higher-order chromatin conformation to restrict enhancer access
RT   to Igf2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:10684-10689(2006).
RN   [16]
RP   FUNCTION.
RX   PubMed=17827499; DOI=10.1074/jbc.m706213200;
RA   Renda M., Baglivo I., Burgess-Beusse B., Esposito S., Fattorusso R.,
RA   Felsenfeld G., Pedone P.V.;
RT   "Critical DNA binding interactions of the insulator protein CTCF: a small
RT   number of zinc fingers mediate strong binding, and a single finger-DNA
RT   interaction controls binding at imprinted loci.";
RL   J. Biol. Chem. 282:33336-33345(2007).
RN   [17]
RP   FUNCTION.
RX   PubMed=18413740; DOI=10.1158/0008-5472.can-07-6654;
RA   Sun L., Huang L., Nguyen P., Bisht K.S., Bar-Sela G., Ho A.S.,
RA   Bradbury C.M., Yu W., Cui H., Lee S., Trepel J.B., Feinberg A.P., Gius D.;
RT   "DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment
RT   of CTCFL/BORIS and modulation of promoter histone methylation.";
RL   Cancer Res. 68:2726-2735(2008).
RN   [18]
RP   FUNCTION.
RX   PubMed=18347100; DOI=10.1084/jem.20071843;
RA   Majumder P., Gomez J.A., Chadwick B.P., Boss J.M.;
RT   "The insulator factor CTCF controls MHC class II gene expression and is
RT   required for the formation of long-distance chromatin interactions.";
RL   J. Exp. Med. 205:785-798(2008).
RN   [19]
RP   FUNCTION.
RX   PubMed=18654629; DOI=10.1371/journal.pgen.1000138;
RA   Fu Y., Sinha M., Peterson C.L., Weng Z.;
RT   "The insulator binding protein CTCF positions 20 nucleosomes around its
RT   binding sites across the human genome.";
RL   PLoS Genet. 4:E1000138-E1000138(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-374; SER-402; SER-609;
RP   SER-610 AND SER-612, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [21]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18550811; DOI=10.1073/pnas.0801273105;
RA   Rubio E.D., Reiss D.J., Welcsh P.L., Disteche C.M., Filippova G.N.,
RA   Baliga N.S., Aebersold R., Ranish J.A., Krumm A.;
RT   "CTCF physically links cohesin to chromatin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:8309-8314(2008).
RN   [22]
RP   FUNCTION.
RX   PubMed=19322193; DOI=10.1038/emboj.2009.81;
RA   Mishiro T., Ishihara K., Hino S., Tsutsumi S., Aburatani H., Shirahige K.,
RA   Kinoshita Y., Nakao M.;
RT   "Architectural roles of multiple chromatin insulators at the human
RT   apolipoprotein gene cluster.";
RL   EMBO J. 28:1234-1245(2009).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-289; THR-317; SER-609;
RP   SER-610 AND SER-612, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-609; SER-610 AND SER-612, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [29]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-689, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [30]
RP   FUNCTION, INTERACTION WITH CENPE, AND SUBCELLULAR LOCATION.
RX   PubMed=26321640; DOI=10.1016/j.celrep.2015.08.005;
RA   Xiao T., Wongtrakoongate P., Trainor C., Felsenfeld G.;
RT   "CTCF recruits centromeric protein CENP-E to the
RT   pericentromeric/centromeric regions of chromosomes through unusual CTCF-
RT   binding sites.";
RL   Cell Rep. 12:1704-1714(2015).
RN   [31]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-18; LYS-219 AND LYS-689, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [32]
RP   STRUCTURE BY NMR OF 399-589.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of zinc finger domains of transcriptional repressor
RT   CTCF protein.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [33]
RP   VARIANT MRD21 TRP-567.
RX   PubMed=23746550; DOI=10.1016/j.ajhg.2013.05.007;
RA   Gregor A., Oti M., Kouwenhoven E.N., Hoyer J., Sticht H., Ekici A.B.,
RA   Kjaergaard S., Rauch A., Stunnenberg H.G., Uebe S., Vasileiou G., Reis A.,
RA   Zhou H., Zweier C.;
RT   "De novo mutations in the genome organizer CTCF cause intellectual
RT   disability.";
RL   Am. J. Hum. Genet. 93:124-131(2013).
RN   [34]
RP   VARIANTS 19-GLY--ARG-727 DEL; CYS-278; HIS-342 AND THR-365,
RP   CHARACTERIZATION OF VARIANTS CYS-278; HIS-342 AND THR-365, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=28319062; DOI=10.1038/onc.2017.25;
RA   Marshall A.D., Bailey C.G., Champ K., Vellozzi M., O'Young P., Metierre C.,
RA   Feng Y., Thoeng A., Richards A.M., Schmitz U., Biro M., Jayasinghe R.,
RA   Ding L., Anderson L., Mardis E.R., Rasko J.E.J.;
RT   "CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic.";
RL   Oncogene 36:4100-4110(2017).
CC   -!- FUNCTION: Chromatin binding factor that binds to DNA sequence specific
CC       sites. Involved in transcriptional regulation by binding to chromatin
CC       insulators and preventing interaction between promoter and nearby
CC       enhancers and silencers. Acts as transcriptional repressor binding to
CC       promoters of vertebrate MYC gene and BAG1 gene. Also binds to the PLK
CC       and PIM1 promoters. Acts as a transcriptional activator of APP.
CC       Regulates APOA1/C3/A4/A5 gene cluster and controls MHC class II gene
CC       expression. Plays an essential role in oocyte and preimplantation
CC       embryo development by activating or repressing transcription. Seems to
CC       act as tumor suppressor. Plays a critical role in the epigenetic
CC       regulation. Participates in the allele-specific gene expression at the
CC       imprinted IGF2/H19 gene locus. On the maternal allele, binding within
CC       the H19 imprinting control region (ICR) mediates maternally inherited
CC       higher-order chromatin conformation to restrict enhancer access to
CC       IGF2. Plays a critical role in gene silencing over considerable
CC       distances in the genome. Preferentially interacts with unmethylated
CC       DNA, preventing spreading of CpG methylation and maintaining
CC       methylation-free zones. Inversely, binding to target sites is prevented
CC       by CpG methylation. Plays an important role in chromatin remodeling.
CC       Can dimerize when it is bound to different DNA sequences, mediating
CC       long-range chromatin looping. Mediates interchromosomal association
CC       between IGF2/H19 and WSB1/NF1 and may direct distant DNA segments to a
CC       common transcription factory. Causes local loss of histone acetylation
CC       and gain of histone methylation in the beta-globin locus, without
CC       affecting transcription. When bound to chromatin, it provides an anchor
CC       point for nucleosomes positioning. Seems to be essential for homologous
CC       X-chromosome pairing. May participate with Tsix in establishing a
CC       regulatable epigenetic switch for X chromosome inactivation. May play a
CC       role in preventing the propagation of stable methylation at the escape
CC       genes from X- inactivation. Involved in sister chromatid cohesion.
CC       Associates with both centromeres and chromosomal arms during metaphase
CC       and required for cohesin localization to CTCF sites. Regulates
CC       asynchronous replication of IGF2/H19. Plays a role in the recruitment
CC       of CENPE to the pericentromeric/centromeric regions of the chromosome
CC       during mitosis (PubMed:26321640). {ECO:0000269|PubMed:11743158,
CC       ECO:0000269|PubMed:16815976, ECO:0000269|PubMed:17827499,
CC       ECO:0000269|PubMed:18347100, ECO:0000269|PubMed:18413740,
CC       ECO:0000269|PubMed:18550811, ECO:0000269|PubMed:18654629,
CC       ECO:0000269|PubMed:19322193, ECO:0000269|PubMed:26321640,
CC       ECO:0000269|PubMed:8649389, ECO:0000269|PubMed:9591631}.
CC   -!- SUBUNIT: Interacts with CHD8 (PubMed:16949368). Interacts with LLPH (By
CC       similarity). Interacts with CENPE (PubMed:26321640).
CC       {ECO:0000250|UniProtKB:Q61164, ECO:0000269|PubMed:16949368,
CC       ECO:0000269|PubMed:26321640}.
CC   -!- INTERACTION:
CC       P49711; P05067: APP; NbExp=3; IntAct=EBI-932887, EBI-77613;
CC       P49711; Q00341: HDLBP; NbExp=4; IntAct=EBI-932887, EBI-1049478;
CC       P49711; Q9UGL1: KDM5B; NbExp=8; IntAct=EBI-932887, EBI-2514978;
CC       P49711; Q01860: POU5F1; NbExp=2; IntAct=EBI-932887, EBI-475687;
CC       P49711; Q12933: TRAF2; NbExp=3; IntAct=EBI-932887, EBI-355744;
CC       P49711; Q5VZL5: ZMYM4; NbExp=3; IntAct=EBI-932887, EBI-2514659;
CC       P49711; O95789-4: ZMYM6; NbExp=3; IntAct=EBI-932887, EBI-12949277;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:28319062}. Chromosome
CC       {ECO:0000269|PubMed:26321640}. Chromosome, centromere
CC       {ECO:0000269|PubMed:26321640}. Note=May translocate to the nucleolus
CC       upon cell differentiation. Associates with both centromeres and
CC       chromosomal arms during metaphase. Associates with the H19 ICR in
CC       mitotic chromosomes. May be preferentially excluded from
CC       heterochromatin during interphase.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49711-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49711-2; Sequence=VSP_045350;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Absent in primary spermatocytes.
CC       {ECO:0000269|PubMed:9591631}.
CC   -!- DOMAIN: The 11 zinc fingers are highly conserved among vertebrates,
CC       exhibiting almost identical amino acid sequences. Different subsets or
CC       combination of individual zinc fingers gives the ability to CTCF to
CC       recognize multiple DNA target sites.
CC   -!- PTM: Sumoylated on Lys-74 and Lys-689; sumoylation of CTCF contributes
CC       to the repressive function of CTCF on the MYC P2 promoter.
CC       {ECO:0000250|UniProtKB:Q61164}.
CC   -!- DISEASE: Intellectual developmental disorder, autosomal dominant 21
CC       (MRD21) [MIM:615502]: A disorder characterized by significantly below
CC       average general intellectual functioning associated with impairments in
CC       adaptive behavior and manifested during the developmental period.
CC       Additional MRD21 features include short stature, microcephaly, and
CC       developmental delay. {ECO:0000269|PubMed:23746550}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: More than 13'00 CTCF-binding sites in potential
CC       insulators were identified in the human genome.
CC   -!- SIMILARITY: Belongs to the CTCF zinc-finger protein family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD93030.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/40187/CTCF";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U25435; AAB07788.1; -; mRNA.
DR   EMBL; AF145477; AAF31318.1; -; Genomic_DNA.
DR   EMBL; AF145468; AAF31318.1; JOINED; Genomic_DNA.
DR   EMBL; AF145469; AAF31318.1; JOINED; Genomic_DNA.
DR   EMBL; AF145470; AAF31318.1; JOINED; Genomic_DNA.
DR   EMBL; AF145471; AAF31318.1; JOINED; Genomic_DNA.
DR   EMBL; AF145472; AAF31318.1; JOINED; Genomic_DNA.
DR   EMBL; AF145473; AAF31318.1; JOINED; Genomic_DNA.
DR   EMBL; AF145474; AAF31318.1; JOINED; Genomic_DNA.
DR   EMBL; AF145475; AAF31318.1; JOINED; Genomic_DNA.
DR   EMBL; AF145476; AAF31318.1; JOINED; Genomic_DNA.
DR   EMBL; BT009915; AAP88917.1; -; mRNA.
DR   EMBL; AB209793; BAD93030.1; ALT_INIT; mRNA.
DR   EMBL; AC009095; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC027682; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471092; EAW83142.1; -; Genomic_DNA.
DR   EMBL; BC014267; AAH14267.1; -; mRNA.
DR   CCDS; CCDS10841.1; -. [P49711-1]
DR   CCDS; CCDS54029.1; -. [P49711-2]
DR   PIR; G01792; G01792.
DR   RefSeq; NP_001177951.1; NM_001191022.1. [P49711-2]
DR   RefSeq; NP_006556.1; NM_006565.3. [P49711-1]
DR   RefSeq; XP_016878357.1; XM_017022868.1. [P49711-1]
DR   PDB; 1X6H; NMR; -; A=515-587.
DR   PDB; 2CT1; NMR; -; A=399-462.
DR   PDB; 5K5H; X-ray; 3.11 A; A=348-464.
DR   PDB; 5K5I; X-ray; 2.19 A; A=378-489.
DR   PDB; 5K5J; X-ray; 2.29 A; A=378-489.
DR   PDB; 5K5L; X-ray; 3.12 A; E/F/G=405-492.
DR   PDB; 5KKQ; X-ray; 1.74 A; A/D=321-465.
DR   PDB; 5T00; X-ray; 2.19 A; A/D=321-465.
DR   PDB; 5T0U; X-ray; 3.20 A; A/D=294-465.
DR   PDB; 5UND; X-ray; 2.55 A; A/B=348-547.
DR   PDB; 5YEF; X-ray; 2.81 A; A/B/G/J=292-490.
DR   PDB; 5YEG; X-ray; 2.00 A; A=349-490, B=349-489.
DR   PDB; 5YEH; X-ray; 2.33 A; A/B=349-490.
DR   PDB; 5YEL; X-ray; 2.96 A; A/B=405-580.
DR   PDB; 6QNX; X-ray; 2.70 A; C=1-727.
DR   PDBsum; 1X6H; -.
DR   PDBsum; 2CT1; -.
DR   PDBsum; 5K5H; -.
DR   PDBsum; 5K5I; -.
DR   PDBsum; 5K5J; -.
DR   PDBsum; 5K5L; -.
DR   PDBsum; 5KKQ; -.
DR   PDBsum; 5T00; -.
DR   PDBsum; 5T0U; -.
DR   PDBsum; 5UND; -.
DR   PDBsum; 5YEF; -.
DR   PDBsum; 5YEG; -.
DR   PDBsum; 5YEH; -.
DR   PDBsum; 5YEL; -.
DR   PDBsum; 6QNX; -.
DR   AlphaFoldDB; P49711; -.
DR   SMR; P49711; -.
DR   BioGRID; 115906; 438.
DR   CORUM; P49711; -.
DR   DIP; DIP-35252N; -.
DR   IntAct; P49711; 120.
DR   MINT; P49711; -.
DR   STRING; 9606.ENSP00000264010; -.
DR   ChEMBL; CHEMBL4523233; -.
DR   GlyGen; P49711; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P49711; -.
DR   PhosphoSitePlus; P49711; -.
DR   SwissPalm; P49711; -.
DR   BioMuta; CTCF; -.
DR   DMDM; 1706179; -.
DR   EPD; P49711; -.
DR   jPOST; P49711; -.
DR   MassIVE; P49711; -.
DR   MaxQB; P49711; -.
DR   PaxDb; P49711; -.
DR   PeptideAtlas; P49711; -.
DR   ProteomicsDB; 56053; -. [P49711-1]
DR   ProteomicsDB; 5985; -.
DR   Antibodypedia; 15816; 492 antibodies from 41 providers.
DR   DNASU; 10664; -.
DR   Ensembl; ENST00000264010.10; ENSP00000264010.4; ENSG00000102974.16. [P49711-1]
DR   Ensembl; ENST00000401394.6; ENSP00000384707.1; ENSG00000102974.16. [P49711-2]
DR   Ensembl; ENST00000642819.1; ENSP00000494408.1; ENSG00000102974.16. [P49711-1]
DR   Ensembl; ENST00000644753.1; ENSP00000493495.1; ENSG00000102974.16. [P49711-1]
DR   Ensembl; ENST00000645699.1; ENSP00000495348.1; ENSG00000102974.16. [P49711-1]
DR   Ensembl; ENST00000646076.1; ENSP00000494538.1; ENSG00000102974.16. [P49711-1]
DR   GeneID; 10664; -.
DR   KEGG; hsa:10664; -.
DR   MANE-Select; ENST00000264010.10; ENSP00000264010.4; NM_006565.4; NP_006556.1.
DR   UCSC; uc002etl.4; human. [P49711-1]
DR   AGR; HGNC:13723; -.
DR   CTD; 10664; -.
DR   DisGeNET; 10664; -.
DR   GeneCards; CTCF; -.
DR   HGNC; HGNC:13723; CTCF.
DR   HPA; ENSG00000102974; Low tissue specificity.
DR   MalaCards; CTCF; -.
DR   MIM; 604167; gene.
DR   MIM; 615502; phenotype.
DR   neXtProt; NX_P49711; -.
DR   OpenTargets; ENSG00000102974; -.
DR   Orphanet; 363611; CTCF-related neurodevelopmental disorder.
DR   PharmGKB; PA26998; -.
DR   VEuPathDB; HostDB:ENSG00000102974; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000156672; -.
DR   HOGENOM; CLU_002678_77_1_1; -.
DR   InParanoid; P49711; -.
DR   OMA; TESEPMI; -.
DR   OrthoDB; 5398475at2759; -.
DR   PhylomeDB; P49711; -.
DR   TreeFam; TF106430; -.
DR   PathwayCommons; P49711; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   SignaLink; P49711; -.
DR   SIGNOR; P49711; -.
DR   BioGRID-ORCS; 10664; 822 hits in 1212 CRISPR screens.
DR   ChiTaRS; CTCF; human.
DR   EvolutionaryTrace; P49711; -.
DR   GeneWiki; CTCF; -.
DR   GenomeRNAi; 10664; -.
DR   Pharos; P49711; Tbio.
DR   PRO; PR:P49711; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; P49711; protein.
DR   Bgee; ENSG00000102974; Expressed in ventricular zone and 212 other tissues.
DR   ExpressionAtlas; P49711; baseline and differential.
DR   Genevisible; P49711; HS.
DR   GO; GO:0000775; C:chromosome, centromeric region; IDA:UniProtKB.
DR   GO; GO:0000793; C:condensed chromosome; IDA:UniProtKB.
DR   GO; GO:0001673; C:male germ cell nucleus; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043035; F:chromatin insulator sequence binding; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:UniProtKB.
DR   GO; GO:0001221; F:transcription coregulator binding; IPI:ARUK-UCL.
DR   GO; GO:0008270; F:zinc ion binding; TAS:UniProtKB.
DR   GO; GO:0140588; P:chromatin looping; IDA:GO_Central.
DR   GO; GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW.
DR   GO; GO:0006306; P:DNA methylation; IEA:Ensembl.
DR   GO; GO:0040029; P:epigenetic regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0071514; P:genomic imprinting; IDA:GO_Central.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0044027; P:negative regulation of gene expression via CpG island methylation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; IMP:UniProtKB.
DR   GO; GO:0070602; P:regulation of centromeric sister chromatid cohesion; NAS:UniProtKB.
DR   GO; GO:0006349; P:regulation of gene expression by genomic imprinting; IEA:Ensembl.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 8.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24379:SF81; CCCTC-BINDING FACTOR-LIKE; 1.
DR   PANTHER; PTHR24379; KRAB AND ZINC FINGER DOMAIN-CONTAINING; 1.
DR   Pfam; PF00096; zf-C2H2; 6.
DR   Pfam; PF13909; zf-H2C2_5; 1.
DR   SMART; SM00355; ZnF_C2H2; 11.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 7.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 8.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 11.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing; Centromere;
KW   Chromatin regulator; Chromosome; Chromosome partition;
KW   Direct protein sequencing; Disease variant; DNA-binding;
KW   Intellectual disability; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Tumor suppressor; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..727
FT                   /note="Transcriptional repressor CTCF"
FT                   /id="PRO_0000047228"
FT   ZN_FING         266..288
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         294..316
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         322..345
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         351..373
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         379..401
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         407..430
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         437..460
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         467..489
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         495..517
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         523..546
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         555..577
FT                   /note="C2H2-type 11; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          180..211
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          573..677
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          689..717
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        613..633
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        634..650
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        658..677
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         289
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         317
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         374
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         402
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         609
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         610
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         612
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   CROSSLNK        18
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        74
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        219
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        689
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..328
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_045350"
FT   VARIANT         19..727
FT                   /note="Missing (found in an endometrial carcinoma sample;
FT                   unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:28319062"
FT                   /id="VAR_079374"
FT   VARIANT         278
FT                   /note="R -> C (found in an endometrial carcinoma sample; no
FT                   effect on its nuclear localization; loss of its ability to
FT                   inhibit cell proliferation; unknown pathological
FT                   significance; dbSNP:rs1266478000)"
FT                   /evidence="ECO:0000269|PubMed:28319062"
FT                   /id="VAR_079375"
FT   VARIANT         339
FT                   /note="R -> W (in a Wilms' tumor; dbSNP:rs1243010179)"
FT                   /evidence="ECO:0000269|PubMed:11782357"
FT                   /id="VAR_013141"
FT   VARIANT         342
FT                   /note="R -> H (found in an endometrial carcinoma sample; no
FT                   effect on its nuclear localization; loss of its ability to
FT                   inhibit cell proliferation; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:28319062"
FT                   /id="VAR_079376"
FT   VARIANT         344
FT                   /note="K -> E (in a breast tumor; dbSNP:rs1215280530)"
FT                   /evidence="ECO:0000269|PubMed:11782357"
FT                   /id="VAR_013142"
FT   VARIANT         345
FT                   /note="H -> R (in a prostate tumor)"
FT                   /evidence="ECO:0000269|PubMed:11782357"
FT                   /id="VAR_013143"
FT   VARIANT         365
FT                   /note="K -> T (found in an endometrial carcinoma sample; no
FT                   effect on its nuclear localization; no loss of its ability
FT                   to inhibit cell proliferation; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:28319062"
FT                   /id="VAR_079377"
FT   VARIANT         448
FT                   /note="R -> Q (in a Wilms' tumor)"
FT                   /evidence="ECO:0000269|PubMed:11782357"
FT                   /id="VAR_013144"
FT   VARIANT         567
FT                   /note="R -> W (in MRD21; dbSNP:rs879255516)"
FT                   /evidence="ECO:0000269|PubMed:23746550"
FT                   /id="VAR_070776"
FT   HELIX           224..226
FT                   /evidence="ECO:0007829|PDB:6QNX"
FT   STRAND          297..300
FT                   /evidence="ECO:0007829|PDB:5T0U"
FT   STRAND          302..305
FT                   /evidence="ECO:0007829|PDB:5T0U"
FT   HELIX           306..316
FT                   /evidence="ECO:0007829|PDB:5T0U"
FT   STRAND          325..327
FT                   /evidence="ECO:0007829|PDB:5YEF"
FT   STRAND          330..333
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   HELIX           334..344
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   STRAND          354..357
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   STRAND          359..362
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   HELIX           363..374
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   STRAND          382..385
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   STRAND          387..390
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   HELIX           391..402
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   STRAND          406..408
FT                   /evidence="ECO:0007829|PDB:2CT1"
FT   TURN            410..412
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   STRAND          415..418
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   HELIX           419..429
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   HELIX           431..433
FT                   /evidence="ECO:0007829|PDB:5K5L"
FT   STRAND          437..439
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   TURN            440..443
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   STRAND          444..448
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   HELIX           449..459
FT                   /evidence="ECO:0007829|PDB:5KKQ"
FT   STRAND          460..468
FT                   /evidence="ECO:0007829|PDB:5YEF"
FT   STRAND          470..473
FT                   /evidence="ECO:0007829|PDB:5YEG"
FT   STRAND          475..478
FT                   /evidence="ECO:0007829|PDB:5YEG"
FT   HELIX           479..486
FT                   /evidence="ECO:0007829|PDB:5YEG"
FT   TURN            489..493
FT                   /evidence="ECO:0007829|PDB:5UND"
FT   STRAND          498..500
FT                   /evidence="ECO:0007829|PDB:5UND"
FT   STRAND          503..506
FT                   /evidence="ECO:0007829|PDB:5YEL"
FT   HELIX           507..514
FT                   /evidence="ECO:0007829|PDB:5UND"
FT   STRAND          526..529
FT                   /evidence="ECO:0007829|PDB:5YEL"
FT   STRAND          531..535
FT                   /evidence="ECO:0007829|PDB:5YEL"
FT   HELIX           536..540
FT                   /evidence="ECO:0007829|PDB:5YEL"
FT   HELIX           541..545
FT                   /evidence="ECO:0007829|PDB:5YEL"
FT   STRAND          558..560
FT                   /evidence="ECO:0007829|PDB:5YEL"
FT   STRAND          563..565
FT                   /evidence="ECO:0007829|PDB:1X6H"
FT   HELIX           567..575
FT                   /evidence="ECO:0007829|PDB:5YEL"
SQ   SEQUENCE   727 AA;  82785 MW;  2110538B65DC5706 CRC64;
     MEGDAVEAIV EESETFIKGK ERKTYQRRRE GGQEEDACHL PQNQTDGGEV VQDVNSSVQM
     VMMEQLDPTL LQMKTEVMEG TVAPEAEAAV DDTQIITLQV VNMEEQPINI GELQLVQVPV
     PVTVPVATTS VEELQGAYEN EVSKEGLAES EPMICHTLPL PEGFQVVKVG ANGEVETLEQ
     GELPPQEDPS WQKDPDYQPP AKKTKKTKKS KLRYTEEGKD VDVSVYDFEE EQQEGLLSEV
     NAEKVVGNMK PPKPTKIKKK GVKKTFQCEL CSYTCPRRSN LDRHMKSHTD ERPHKCHLCG
     RAFRTVTLLR NHLNTHTGTR PHKCPDCDMA FVTSGELVRH RRYKHTHEKP FKCSMCDYAS
     VEVSKLKRHI RSHTGERPFQ CSLCSYASRD TYKLKRHMRT HSGEKPYECY ICHARFTQSG
     TMKMHILQKH TENVAKFHCP HCDTVIARKS DLGVHLRKQH SYIEQGKKCR YCDAVFHERY
     ALIQHQKSHK NEKRFKCDQC DYACRQERHM IMHKRTHTGE KPYACSHCDK TFRQKQLLDM
     HFKRYHDPNF VPAAFVCSKC GKTFTRRNTM ARHADNCAGP DGVEGENGGE TKKSKRGRKR
     KMRSKKEDSS DSENAEPDLD DNEDEEEPAV EIEPEPEPQP VTPAPPPAKK RRGRPPGRTN
     QPKQNQPTAI IQVEDQNTGA IENIIVEVKK EPDAEPAEGE EEEAQPAATD APNGDLTPEM
     ILSMMDR
//
